Transfusions of Blood Products Derived from Genetic Vaccine Recipients: Safety Concerns and Proposals for Specific Measures DOI Open Access
Jun Ueda, Hideyuki Motohashi,

Yuriko Hirai

et al.

Published: May 29, 2024

The World Health Organization declared the coronavirus disease 2019 (COVID-19) pandemic in 2020, following which a global genetic vaccination program has been rapidly implemented as fundamental solution. However, it reported worldwide that modified mRNAs encoding spike proteins and lipid nanoparticles, are used drug delivery systems, not only cause thrombosis cardiovascular disorders post vaccination, but might also diverse diseases involving all organs including nervous system. Furthermore, toxicity pathogenicity of may necessitate defining these nonbiological infective material. Based on reports abundant evidence come to light past few years, this paper aims draw attention medical professionals various risks associated with transfusion using blood products derived from long COVID patients or vaccine recipients, make proposals regarding specific inspection items, testing methods, regulations, etc. This provides insights address post-vaccination syndrome its consequences such programs.

Language: Английский

Transfusions of Blood Products Derived from Genetic Vaccine Recipients: Safety Concerns and Proposals for Specific Measures DOI Open Access
Jun Ueda, Hideyuki Motohashi,

Yuriko Hirai

et al.

Published: May 29, 2024

The World Health Organization declared the coronavirus disease 2019 (COVID-19) pandemic in 2020, following which a global genetic vaccination program has been rapidly implemented as fundamental solution. However, it reported worldwide that modified mRNAs encoding spike proteins and lipid nanoparticles, are used drug delivery systems, not only cause thrombosis cardiovascular disorders post vaccination, but might also diverse diseases involving all organs including nervous system. Furthermore, toxicity pathogenicity of may necessitate defining these nonbiological infective material. Based on reports abundant evidence come to light past few years, this paper aims draw attention medical professionals various risks associated with transfusion using blood products derived from long COVID patients or vaccine recipients, make proposals regarding specific inspection items, testing methods, regulations, etc. This provides insights address post-vaccination syndrome its consequences such programs.

Language: Английский

Citations

1